CD4 and neoplasm: Moreover, when agonists specific for the costimulatory molecules CD134 and CD137 were applied in mouse tumor models, eomesodermin (Eomes), which promotes the production of granzyme (Grm)B, was upregulated in CD4 CTLs [9].